Skip to content

13F-HR/A filed by Eversept Partners, LP

Eversept Partners, LP filed this 13F-HR/A for the quarter ended 2019-09-30, filed 2023-11-08, with 57 holding rows worth $322,353,072.

Accession
0001697013-23-000013
Filed
2023-11-08
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, amendment of type restatement, 57 entries on the cover page, a total value of $322,353,072 stated on the cover page (in dollars after the unit check, H1), rows summing to $322,353,072 with VALUE read as dollars as filed, 13F file number 028-18369. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR983,085$42,337,144dollars as filed
ENSIGN GROUP INC29358P101COM586,674$27,849,345dollars as filed
Danaher Corporation235851102COM178,704$25,838,590dollars as filed
ZOGENIX INC.98978L204Common Stock643,818$25,778,473dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR236,392$22,769,277dollars as filed
AMARIN CORP PLC023111206SPONS ADR NEW1,329,695$20,158,176dollars as filed
SANOFI SA SPONSORED ADR80105N105ADR240,000$11,119,200dollars as filed
RADIUS HEALTH INC750469207COM NEW344,698$8,875,974dollars as filed
ENVISTA HOLDINGS CORPORATION29415F104COM318,000$8,865,840dollars as filed
Vertex Pharmaceuticals Incorporated92532F100COM50,909$8,625,003dollars as filed
ILLUMINA INC452327109COM26,750$8,137,885dollars as filed
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock92,040$7,401,857dollars as filed
AUDENTES THERAPEUTICS INC.05070R104Common Stock253,726$7,127,163dollars as filed
DEXCOM INC COM252131107Stock44,550$6,648,642dollars as filed
R1 RCM INC749397105COM725,972$6,482,930dollars as filed
ABIOMED INC003654100COM29,950$5,327,806dollars as filed
OMEGA HEALTHCARE INVS INC COM681936100REIT106,500$4,450,635dollars as filed
TG THERAPEUTICS INC COM88322Q108Stock773,501$4,343,208dollars as filed
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS256,000$4,257,280dollars as filed
TELIGENT INC NEW87960W104COM4,424,222$4,202,126dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR36,004$4,103,016dollars as filed
LTC PPTYS INC COM502175102REIT69,327$3,550,929dollars as filed
SABRA HEALTH CARE REIT INC COM78573L106REIT154,100$3,538,136dollars as filed
MODEL N INC607525102COM120,695$3,350,493dollars as filed
CARETRUST REIT INC COM14174T107REIT137,464$3,259,950dollars as filed
BIODELIVERY SCIENCES INTL IN09060J106COM708,020$2,980,764dollars as filed
ARQULE INC04269E107COM412,388$2,956,822dollars as filed
HESKA CORP42805E306COM40,824$2,893,197dollars as filed
EHEALTH INC28238P109COM42,653$2,848,794dollars as filed
AMARIN CORP PLC023111206SPONS ADR NEW161,100$2,442,276dollars as filedcall
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK607,383$2,186,579dollars as filed
FATE THERAPEUTICS INC31189P102COM140,656$2,184,388dollars as filed
CYTOKINETICS INC23282W605COM NEW181,700$2,067,746dollars as filed
TRICIDA INC89610F101COM65,568$2,024,084dollars as filed
MACROGENICS INC556099109COM154,824$1,975,554dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock215,609$1,942,637dollars as filed
APELLIS PHARMACEUTICALS INC03753U106COM79,509$1,915,372dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock654,460$1,875,028dollars as filed
COLLEGIUM PHARMACEUTICAL INC19459J104COM160,295$1,840,187dollars as filed
SCPHARMACEUTICALS INC810648105COM221,636$1,301,003dollars as filed
AGILE THERAPEUTICS INC00847L100COM909,485$1,077,740dollars as filed
INVACARE CORP461203101COMMON STOCK129,361$970,208dollars as filed
AFFIMED N VN01045108COM322,171$947,183dollars as filed
OTONOMY INC68906L105COM376,342$899,457dollars as filed
CODEXIS INC192005106COM63,000$864,045dollars as filed
SAVARA INC805111101COM316,679$839,199dollars as filed
DECIPHERA PHARMACEUTICALS IN24344T101COM22,000$746,680dollars as filed
OPTINOSE INC68404V100COM105,106$735,742dollars as filed
EIGER BIOPHARMACEUTICALS INC28249U105COM69,708$714,507dollars as filed
DICERNA PHARMACEUTICALS INC253031108COM41,074$589,823dollars as filed
NEWLINK GENETICS CORP651511107COM272,983$434,043dollars as filed
PFENEX INC717071104COM47,968$404,850dollars as filed
CEL-SCI CORP150837607COM PAR NEW42,800$382,632dollars as filedput
ALBIREO PHARMA INC01345P106COMMON STOCK18,029$360,580dollars as filed
AIMMUNE THERAPEUTICS INC.00900T107Common Stock10,000$209,400dollars as filedput
AIMMUNE THERAPEUTICS INC.00900T107Common Stock9,100$190,554dollars as filedcall
AKORN INC009728106COM40,242$152,920dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001697013-19-000012 superseded2019-11-13acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000013this filing2023-11-08acceptance time not in the bulk data set